Volume 11, Issue 3 (9-2023)                   JoMMID 2023, 11(3): 136-140 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Setayesh Nia M, Elikaei A, Abdi Ali A, Rezaei Z. Isolation and Identification of a Sewage Pseudomonas aeruginosa-infecting Bacteriophage. JoMMID 2023; 11 (3) :136-140
URL: http://jommid.pasteur.ac.ir/article-1-567-en.html
Department of Microbiology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran
Abstract:   (745 Views)
Introduction: Pseudomonas aeruginosa, a nosocomial pathogen, causes respiratory infections, particularly in individuals with cystic fibrosis (CF); it poses a significant challenge due to escalating antibiotic resistance. Phage therapy is emerging as a potential alternative approach to treating antibiotic-resistant bacteria. This study aimed to isolate and identify a highly efficacious bacteriophage targeting P. aeruginosa. Methods: Sewage samples from Mofid Children's Hospital were collected and titrated using a double-layer plaque assay. After plaque detection, the phage was isolated, and then the host range, adsorption rate, and stability were evaluated through spot tests and double-layer plaque assays. Phage morphology was determined using transmission electron microscopy (TEM). Results: Of the three sewage samples collected, one contained phage. We isolated a lytic bacteriophage that exhibited clear plaque formation and induced lysis in planktonic P. aeruginosa. TEM analysis revealed that the phage belonged to the Myoviridae family. The phage had a broad host range and demonstrated optimal stability at 37 °C and pH 7. Conclusion: The isolated phage can potentially be used for treating P. aeruginosa lung infections, offering an alternative approach to address drug-resistant isolates.
Full-Text [PDF 1024 kb]   (223 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2023/06/17 | Accepted: 2023/09/10 | Published: 2023/11/11

1. Lerdsittikul V, Thongdee M, Chaiwattanarungruengpaisan S, Atithep T, Apiratwarrasakul S, Withatanung P, et al. A novel virulent Litunavirus phage possesses therapeutic value against multidrug-resistant Pseudomonas aeruginosa. Sci Rep. 2022; 12 (1): 21193. [DOI:10.1038/s41598-022-25576-6] [PMID] [PMCID]
2. Chan BK, Stanley G, Modak M, Koff JL, Turner PE. Bacteriophage therapy for infections in CF. Pediatr Pulmonol. 2021; 56 (S1): S4-9. [DOI:10.1002/ppul.25190]
3. Azizian R, Nasser A, Askari H, Kalani MT, Sadeghifard N, Pakzad, I, et al. Sewage as a rich source of phage study against Pseudomonas aeruginosa PAO. Biologicals. 2015; 43 (4): 238-41. [DOI:10.1016/j.biologicals.2015.05.004] [PMID]
4. Rezaei Z, Elikaei A, Barzi SM, Shafiei M. Isolation, characterization, and antibacterial activity of lytic bacteriophage against methicillin-resistant Staphylococcus aureus causing bedsore and diabetic wounds. Iran J Microbiol. 2022; 14 (5): 712-20. [DOI:10.18502/ijm.v14i5.10967] [PMID] [PMCID]
5. Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage. 2011; 1 (2): 111-4. [DOI:10.4161/bact.1.2.14590] [PMID] [PMCID]
6. Bonilla N, Barr JJ. Phage on Tap: A Quick and Efficient Protocol for the Preparation of Bacteriophage Laboratory Stocks. Methods Mol Biol. 2018; 1838: 37-46. [DOI:10.1007/978-1-4939-8682-8_4] [PMID]
7. Yu P, Mathieu J, Li M, Dai Z, Alvarez PJ. Isolation of Polyvalent Bacteriophages by Sequential Multiple-Host Approaches. Appl Environ Microbiol. 2015; 82 (3): 808-15. [DOI:10.1128/AEM.02382-15] [PMID] [PMCID]
8. Dallal MMS, Nikkhahi F, Alimohammadi M, Douraghi M, Rajabi Z, Foroushani AR, et al. Phage Therapy as an Approach to Control Salmonella enterica serotype Enteritidis Infection in Mice. Rev Soc Bras Med Trop. 2019; 52: e20190290. [DOI:10.1590/0037-8682-0290-2019] [PMID]
9. Manohar P, Tamhankar AJ, Lundborg CS, Nachimuthu R. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species. Front Microbiol. 2019; 10: 574. [DOI:10.3389/fmicb.2019.00574] [PMID] [PMCID]
10. Yang X, Haque A, Matsuzaki S, Matsumoto T, Nakamura S. The Efficacy of Phage Therapy in a Murine Model of Pseudomonas aeruginosa Pneumonia and Sepsis. Front Microbiol. 2021; 12: 1-9. [DOI:10.3389/fmicb.2021.682255] [PMID] [PMCID]
11. Alhazmi A. Pseudomonas aeruginosa-pathogenesis and pathogenic mechanisms. IJB. 2015; 7 (2): 44-67. [DOI:10.5539/ijb.v7n2p44]
12. Silva C, Sá S, Guedes C, Oliveira C, Lima C, Oliveira M, et al. The History and Applications of Phage Therapy in Pseudomonas aeruginosa. Microbiol Res (Pavia). 2021; 13 (1): 14-37. [DOI:10.3390/microbiolres13010002]
13. De Melo ACC, Da Mata Gomes A, Melo FL, Ardisson-Araújo DMP, De Vargas APC, Ely VL, et al. Characterization of a bacteriophage with broad host range against strains of Pseudomonas aeruginosa isolated from domestic animals. BMC Microbiol. 2019; 19 (1): 1-15. [DOI:10.1186/s12866-019-1481-z] [PMID] [PMCID]
14. Homan Y, Rosenbloom D, Wong S, Lucchese J, Li A, Dubey Sh, Thomas J. Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling. Bioanalysi. 2022; 14 (17): 1177-90. [DOI:10.4155/bio-2022-0101] [PMID]
15. Pallavali RR, Degati VL, Lomada D, Reddy MC, Durbaka VRP. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections. PLoS One. 2017; 12 (7): e0179245. [DOI:10.1371/journal.pone.0179245] [PMID] [PMCID]
16. Taha OA, Connerton PL, Connerton IF, El-Shibiny A. Bacteriophage ZCKP1: A potential treatment for Klebsiella pneumoniae isolated from diabetic foot patients. Front Microbiol. 2018; 9: 2127. [DOI:10.3389/fmicb.2018.02127] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.